Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Frailty | 5 | 2019 | 34 | 2.260 |
Why?
|
Postoperative Complications | 12 | 2022 | 1615 | 1.600 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2019 | 146 | 1.250 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2019 | 130 | 1.130 |
Why?
|
Fracture Fixation, Intramedullary | 2 | 2022 | 33 | 0.840 |
Why?
|
Femur | 3 | 2018 | 113 | 0.800 |
Why?
|
Perioperative Care | 2 | 2019 | 100 | 0.780 |
Why?
|
Bone Screws | 2 | 2018 | 90 | 0.750 |
Why?
|
Fracture Fixation | 1 | 2019 | 32 | 0.670 |
Why?
|
Hip Fractures | 1 | 2019 | 26 | 0.670 |
Why?
|
Reoperation | 2 | 2019 | 467 | 0.660 |
Why?
|
Acromion | 1 | 2018 | 3 | 0.650 |
Why?
|
Myocutaneous Flap | 1 | 2018 | 6 | 0.650 |
Why?
|
Bone Diseases, Developmental | 1 | 2018 | 15 | 0.640 |
Why?
|
Joint Diseases | 1 | 2018 | 37 | 0.640 |
Why?
|
Bone Transplantation | 1 | 2018 | 43 | 0.630 |
Why?
|
Osteotomy | 1 | 2018 | 46 | 0.630 |
Why?
|
Health Status Indicators | 1 | 2018 | 117 | 0.620 |
Why?
|
Soft Tissue Injuries | 1 | 2017 | 8 | 0.610 |
Why?
|
Free Tissue Flaps | 1 | 2018 | 67 | 0.610 |
Why?
|
Knee Injuries | 1 | 2017 | 31 | 0.600 |
Why?
|
Surgical Flaps | 1 | 2017 | 120 | 0.560 |
Why?
|
Arthroscopy | 4 | 2020 | 95 | 0.520 |
Why?
|
Carcinoma, Bronchogenic | 1 | 2014 | 18 | 0.500 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 28 | 0.490 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 396 | 0.480 |
Why?
|
Hand | 1 | 2014 | 90 | 0.480 |
Why?
|
Risk Assessment | 2 | 2019 | 2004 | 0.460 |
Why?
|
Databases, Factual | 6 | 2020 | 621 | 0.400 |
Why?
|
Retrospective Studies | 12 | 2022 | 7268 | 0.380 |
Why?
|
Limb Salvage | 2 | 2020 | 39 | 0.360 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 624 | 0.340 |
Why?
|
Radiography | 2 | 2015 | 572 | 0.330 |
Why?
|
Morbidity | 2 | 2019 | 130 | 0.320 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 112 | 0.320 |
Why?
|
Postoperative Care | 1 | 2009 | 163 | 0.320 |
Why?
|
Middle Aged | 12 | 2020 | 21119 | 0.320 |
Why?
|
Aged | 10 | 2020 | 14842 | 0.320 |
Why?
|
Spinal Fusion | 1 | 2009 | 90 | 0.320 |
Why?
|
Comorbidity | 4 | 2019 | 1425 | 0.300 |
Why?
|
United States | 8 | 2020 | 7338 | 0.290 |
Why?
|
Ossification, Heterotopic | 2 | 2018 | 45 | 0.270 |
Why?
|
Humans | 21 | 2022 | 68549 | 0.260 |
Why?
|
Male | 13 | 2020 | 37283 | 0.250 |
Why?
|
Young Adult | 7 | 2020 | 5710 | 0.240 |
Why?
|
Adult | 11 | 2020 | 21379 | 0.240 |
Why?
|
Female | 14 | 2020 | 38021 | 0.230 |
Why?
|
Bone Nails | 2 | 2022 | 32 | 0.210 |
Why?
|
Fractures, Spontaneous | 1 | 2022 | 7 | 0.210 |
Why?
|
Lower Extremity | 2 | 2021 | 153 | 0.210 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 207 | 0.200 |
Why?
|
Length of Stay | 3 | 2019 | 780 | 0.200 |
Why?
|
Soft Tissue Infections | 1 | 2020 | 19 | 0.190 |
Why?
|
Orthopedics | 1 | 2021 | 88 | 0.180 |
Why?
|
Patient Discharge | 2 | 2019 | 294 | 0.180 |
Why?
|
Survival Rate | 2 | 2019 | 1055 | 0.170 |
Why?
|
Health Status | 2 | 2019 | 429 | 0.170 |
Why?
|
Patient Readmission | 2 | 2019 | 267 | 0.170 |
Why?
|
Osteosarcoma | 1 | 2019 | 35 | 0.170 |
Why?
|
Rotator Cuff Injuries | 1 | 2019 | 32 | 0.170 |
Why?
|
Ischemia | 1 | 2020 | 229 | 0.170 |
Why?
|
Salvage Therapy | 1 | 2019 | 82 | 0.170 |
Why?
|
Patient Admission | 1 | 2019 | 99 | 0.170 |
Why?
|
Mortality | 1 | 2019 | 162 | 0.160 |
Why?
|
Bone Neoplasms | 1 | 2019 | 100 | 0.160 |
Why?
|
Risk Factors | 5 | 2020 | 5720 | 0.160 |
Why?
|
Thigh | 1 | 2018 | 27 | 0.160 |
Why?
|
Models, Anatomic | 1 | 2018 | 51 | 0.160 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 91 | 0.160 |
Why?
|
Arthroplasty, Replacement, Shoulder | 1 | 2019 | 41 | 0.160 |
Why?
|
Postoperative Period | 1 | 2019 | 238 | 0.160 |
Why?
|
Femoral Fractures | 1 | 2018 | 45 | 0.160 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2019 | 99 | 0.160 |
Why?
|
Quality Improvement | 2 | 2019 | 413 | 0.160 |
Why?
|
Aged, 80 and over | 3 | 2019 | 4843 | 0.150 |
Why?
|
Brain Concussion | 1 | 2018 | 27 | 0.150 |
Why?
|
Femoral Neoplasms | 1 | 2017 | 7 | 0.150 |
Why?
|
Fibrosarcoma | 1 | 2017 | 21 | 0.150 |
Why?
|
Biomechanical Phenomena | 1 | 2018 | 368 | 0.150 |
Why?
|
Adolescent | 6 | 2020 | 8904 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2020 | 378 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 266 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 1085 | 0.140 |
Why?
|
Internship and Residency | 1 | 2021 | 596 | 0.130 |
Why?
|
Logistic Models | 1 | 2019 | 1419 | 0.130 |
Why?
|
Acetabulum | 1 | 2015 | 20 | 0.130 |
Why?
|
Fracture Fixation, Internal | 1 | 2015 | 68 | 0.120 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 529 | 0.120 |
Why?
|
Fractures, Bone | 1 | 2015 | 132 | 0.120 |
Why?
|
Mitochondria | 1 | 2019 | 643 | 0.120 |
Why?
|
Internal Fixators | 1 | 2009 | 23 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2009 | 121 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2009 | 43 | 0.080 |
Why?
|
Cerebellar Diseases | 1 | 2008 | 6 | 0.080 |
Why?
|
Genetic Diseases, Inborn | 1 | 2008 | 24 | 0.080 |
Why?
|
Cerebellum | 1 | 2008 | 103 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2014 | 1172 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 1465 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 1753 | 0.060 |
Why?
|
Odds Ratio | 2 | 2019 | 880 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2022 | 7028 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 694 | 0.060 |
Why?
|
Operative Time | 1 | 2021 | 45 | 0.050 |
Why?
|
Datasets as Topic | 1 | 2020 | 52 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 3256 | 0.050 |
Why?
|
Peripheral Vascular Diseases | 1 | 2020 | 50 | 0.050 |
Why?
|
Heart Failure | 2 | 2019 | 1179 | 0.050 |
Why?
|
Hypertension | 2 | 2019 | 1533 | 0.040 |
Why?
|
Propensity Score | 1 | 2019 | 116 | 0.040 |
Why?
|
Risk | 1 | 2020 | 563 | 0.040 |
Why?
|
Shoulder | 1 | 2019 | 37 | 0.040 |
Why?
|
SEER Program | 1 | 2019 | 150 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2019 | 2455 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 61 | 0.040 |
Why?
|
Disabled Persons | 1 | 2019 | 94 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2019 | 75 | 0.040 |
Why?
|
eIF-2 Kinase | 1 | 2019 | 49 | 0.040 |
Why?
|
Sarcoma | 1 | 2019 | 70 | 0.040 |
Why?
|
Oxidoreductases | 1 | 2019 | 117 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2020 | 204 | 0.040 |
Why?
|
Infant | 2 | 2019 | 2891 | 0.040 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2019 | 87 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2019 | 148 | 0.040 |
Why?
|
Child, Preschool | 2 | 2019 | 3187 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 2324 | 0.040 |
Why?
|
Hospitals | 1 | 2020 | 265 | 0.040 |
Why?
|
Regression Analysis | 1 | 2019 | 737 | 0.040 |
Why?
|
Immunotherapy | 1 | 2019 | 215 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2017 | 191 | 0.040 |
Why?
|
Insulin | 1 | 2020 | 617 | 0.030 |
Why?
|
Tibia | 1 | 2017 | 93 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 499 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2019 | 1046 | 0.030 |
Why?
|
Clinical Competence | 1 | 2021 | 657 | 0.030 |
Why?
|
Cohort Studies | 1 | 2020 | 2356 | 0.030 |
Why?
|
Prognosis | 1 | 2019 | 2093 | 0.030 |
Why?
|
Child | 2 | 2019 | 6401 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 1140 | 0.030 |
Why?
|
Contrast Media | 1 | 2017 | 595 | 0.030 |
Why?
|
Hospitalization | 1 | 2019 | 977 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2015 | 1549 | 0.020 |
Why?
|
Signal Transduction | 1 | 2019 | 2689 | 0.020 |
Why?
|
Anisotropy | 1 | 2008 | 105 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 2222 | 0.020 |
Why?
|
Pyramidal Tracts | 1 | 2008 | 45 | 0.020 |
Why?
|
Syndrome | 1 | 2008 | 255 | 0.020 |
Why?
|
Mice | 1 | 2019 | 8474 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 239 | 0.020 |
Why?
|
Animals | 1 | 2019 | 20880 | 0.010 |
Why?
|